NRCM
CLBT icon

Northern Right Capital Management’s Cellebrite CLBT Stock Holding History

Northern Right Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,233,048
Closed -$8.88M – 28
2023
Q2 		$8.88M Buy
1,233,048
+202,840
+20% +$1.18M 3.58% 9
2023
Q1 		$6.27M Buy
+1,030,208
New +$5.58M 3.18% 12

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $952M AUM 13.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Right Capital Management's CLBT Position: Q3 2023 in Review

Northern Right Capital Management sold out of Cellebrite (CLBT) in Q3 2023, closing a stake of 1,233,048 shares — an estimated $8.88M sold.

Northern Right Capital Management first reported a position in CLBT in Q1 2023 and held it in 2 quarters. The position peaked at $8.88M in Q2 2023. 94 funds tracked by Wall St. Rank hold CLBT as of Q3 2023.

  • Northern Right Capital Management reported no remaining Cellebrite position as of Q3 2023 after selling out during the quarter.
  • Northern Right Capital Management sold 1,233,048 Cellebrite shares in Q3 2023, an estimated $8.88M.
  • Northern Right Capital Management first reported a position in Cellebrite in Q1 2023 and held it in 2 quarters.
  • Northern Right Capital Management's Cellebrite position peaked at $8.88M in Q2 2023.
  • 94 funds tracked by Wall St. Rank held Cellebrite as of Q3 2023.

Based on Northern Right Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.